Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
NOVAVAX Add to My Watchlist (NSDQ: NVAX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Novavax 2.05 -0.04 (-1.91%) 1,083,848
9920 Belward Campus Drive
Rockville, MD 20850 US
(240) 268-2000
(484) 931-0150 fax
www.novavax.com
CEO Dr. Rahul Singhvi
Auditor Grant Thornton LLP
Exchange Traded NQ
ISIN Number US6700021040
CIK Number 1000694
NAICS Code 325414
Business Summary
A clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
Number of Employees 69
Share Fundamentals
Market Cap 191.65M
Shares Outstanding 93.49M
Float 89.45M
Short Interest 13.52M
Financial Strength
Revenue (TTM) $321,000
Earnings (TTM) -$35,499,000
Quick Ratio 6.1:1
Current Ratio 6.2:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs